We argue that the global burden of mental illness is underestimated and examine the
reasons for under-estimation to identify five main causes: overlap between psychiatric and …

The classical psychedelic drugs, including psilocybin, lysergic acid diethylamide and
mescaline, were used extensively in psychiatry before they were placed in Schedule I of the …

Background China has experienced a remarkable epidemiological and demographic
transition during the past three decades. Far less is known about this transition at the …

The inefficient and incomplete combustion of solid fuel (SF) is associated with high levels of
indoor air pollutants leading to 3.55 million deaths annually. The risk is higher in women and …

Background We used data from the Global Burden of Diseases, Injuries, and Risk Factors
Study 2010 (GBD 2010) to estimate the burden of disease attributable to mental and …

Depression is a major health problem with a high prevalence and a heavy socioeconomic
burden in western societies. It is associated with atrophy and impaired functioning of cortico …

Major depressive disorder (MDD) will affect one out of every five people in their lifetime and
is the leading cause of disability worldwide. Nevertheless, mechanisms associated with the …

Mounting evidence indicates that there are mental health disparities in the United States that
disadvantage racial/ethnic minorities in medical and mental health settings. Less is known …

Diagnostic criteria for mood disorders including major depressive disorder (MDD) largely
ignore biological factors in favor of behavioral symptoms. Compounding this paucity of …

Introduction Post-COVID-19 complications require simultaneous characterisation and
management to plan policy and health system responses. We describe the 12-month …